Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Clinical efficacy and cost per improved outcome of treatments for generalized myasthenia gravis: evidence from a network meta-analysis and cost-per-responder analysis.
Journal: Current medical research and opinion
Published: July 24, 2026
Assessing efgartigimod dosing patterns and Myasthenia Gravis Activities of Daily Living outcomes in clinical practice: results from a large patient support program database.
Journal: Frontiers in neurology
Published: May 14, 2026
Evaluation of steroid toxicity using the Glucocorticoid Toxicity Index-Metabolic Domains instrument in adults with myasthenia gravis: a real-world study in the USA.
Journal: Journal of comparative effectiveness research
Published: May 08, 2026
Impact of corticosteroid use on comorbidities in patients with myasthenia gravis in the US National Veterans Affairs Health Network.
Journal: Journal of the neurological sciences
Published: October 22, 2025
Reduction in oral glucocorticoid use after efgartigimod initiation in clinical practice among patients with generalized myasthenia gravis.
Journal: Journal of the neurological sciences
Published: May 12, 2025
ADAPT NXT: Fixed Cycles or Every-Other-Week IV Efgartigimod in Generalized Myasthenia Gravis.
Journal: Annals of clinical and translational neurology
Published: December 10, 2024
Risk-Benefit Analysis of Novel Treatments for Patients with Generalized Myasthenia Gravis.
Journal: Advances in therapy
Published: August 14, 2024
Racial disparities in acute care utilization among individuals with myasthenia gravis.
Journal: Frontiers in public health
Published: June 13, 2024
Characteristics and healthcare utilization of patients with myasthenia gravis exacerbation.
Journal: Journal of the neurological sciences
Published: April 08, 2024
Post-hoc analyses from the ADAPT clinical study demonstrate aggregate sustained benefit of Efgartigimod in generalized myasthenia gravis.
Journal: Journal of the neurological sciences
Published: April 04, 2024
Qualitative interviews to support development of a patient-reported companion measure to the Glucocorticoid Toxicity Index.
Journal: Journal of the neurological sciences
Published: November 21, 2023
Last Updated: 09/26/2026